TMTPOST — Shenzhen Ruide Pharmaceutical has completed a first-round financing of nearly 100 million yuan, according to HLC. The round was jointly led by HLC and Qianhai Ark, with Shenzhen SME Guarantee Venture Capital participating as a follower and Kaicheng Capital acting as exclusive financial adviser. Proceeds will accelerate research and commercialization of innovative antiparasitic and dermatology drugs for pets. The company, founded by the team behind the RedDog pet-nutrition brand, operates a 12,000-square-meter GMP-certified veterinary drug factory in Ganzhou, Jiangxi, and is developing products covering common pet conditions including heart, digestive and respiratory diseases.